Table 1.

Demographics and disease characteristics of patients at baseline

CharacteristicCyBorD group (n = 132)DaraCyBorD group (n = 91)
Age, median, y (range) 64 (39-87) 64 (38-82) 
Sex, n (%) 
Male 75 (57) 47 (52) 
Female 57 (43) 44 (48) 
AL isotype, n (%) 
λ 100 (75.8) 71 (78.0) 
κ 32 (24.2) 20 (22.0) 
Involved organs 
Median (range) 2 (1-4) 2 (1-5) 
Distribution, n (%) 
Heart 109 (82.5) 81 (89.0) 
Kidney 79 (59.8) 48 (52.7) 
Liver 23 (17.4) 24 (26.4) 
Other 65 (49.2) 62 (68.1) 
Mayo 2004 staging (with 2015 European modification), n (%) 
12 (11.7) 7 (7.9) 
44 (42.7) 35 (39.3) 
3A 34 (33.0) 29 (32.6) 
3B 12 (11.7) 18 (20.2) 
Mayo 2012 staging, n (%) 
17 (16.5) 7 (7.9) 
23 (22.3) 15 (16.9) 
32 (31.1) 34 (38.2) 
30 (29.1) 33 (37.1) 
Median NT-proBNP level, pg/mL (range) 2 771 (17-31 933) 3 518 (87-43 033) 
Median hs-cTnT, ng/L (range) 46 (0.03-373.1) 58 (5-680) 
Median estimated GFR, mL/min per 1.73 m2 (range) 77 (3-181) 76 (10-153) 
CharacteristicCyBorD group (n = 132)DaraCyBorD group (n = 91)
Age, median, y (range) 64 (39-87) 64 (38-82) 
Sex, n (%) 
Male 75 (57) 47 (52) 
Female 57 (43) 44 (48) 
AL isotype, n (%) 
λ 100 (75.8) 71 (78.0) 
κ 32 (24.2) 20 (22.0) 
Involved organs 
Median (range) 2 (1-4) 2 (1-5) 
Distribution, n (%) 
Heart 109 (82.5) 81 (89.0) 
Kidney 79 (59.8) 48 (52.7) 
Liver 23 (17.4) 24 (26.4) 
Other 65 (49.2) 62 (68.1) 
Mayo 2004 staging (with 2015 European modification), n (%) 
12 (11.7) 7 (7.9) 
44 (42.7) 35 (39.3) 
3A 34 (33.0) 29 (32.6) 
3B 12 (11.7) 18 (20.2) 
Mayo 2012 staging, n (%) 
17 (16.5) 7 (7.9) 
23 (22.3) 15 (16.9) 
32 (31.1) 34 (38.2) 
30 (29.1) 33 (37.1) 
Median NT-proBNP level, pg/mL (range) 2 771 (17-31 933) 3 518 (87-43 033) 
Median hs-cTnT, ng/L (range) 46 (0.03-373.1) 58 (5-680) 
Median estimated GFR, mL/min per 1.73 m2 (range) 77 (3-181) 76 (10-153) 

GFR, glomerular filtration rate; hs-cTnT, high-sensitivity cTnT.

or Create an Account

Close Modal
Close Modal